Results

Total Results: 1,932 records

Showing results for "question".

441. Gout Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout_executive.pdf
     March 01, 2016 - Key Question 1: Acute Gout Treatment a. … Key Question 2: Dietary and Lifestyle Management of Gout a. … Key Question 3: Pharmacologic Management of Hyperuricemia in Gout Patients a. … Key Question 4: Treatment Monitoring of Patients with Gout a. … Key Question 5.

442. Atrial-Fibrillation-Ablation Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-ablation_surveillance.pdf
     May 16, 2013 - Key question #3 Reduction in recurrence rates of AF (PVI vs. C-PVI) No new evidence. … Experts (Cycle 2): One expert stated that conclusions in the key question # 1 are still valid. … Experts (Cycle 2): One expert stated that conclusions in the key question # 2 are still valid. … Experts (Cycle 2): One expert stated that conclusions in the key question # 3 are still valid. … Experts (Cycle 2): One expert stated that conclusions in the key question # 4 are still valid.

443. Disposition of Comments for Use of Natriuretic Peptide Measurement in the Management of Heart Failure (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-failure-natriuretic-peptide_disposition-comments.pdf
     November 20, 2013 - Rev 7 Intro In question #6, this question could have been further divided whether BNP/NT-proBNP guided … OR is this more a monitoring question? … We have included the QUADAS question on threshold in the assessment of Risk of Bias. … The signaling question asks about “inappropriate” exclusions. … The target population and key elements of each question are explicitly defined.

444. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gerd-2005_executive.pdf
     January 01, 2005 - Summary of Comparative Data on Treatments of GERD Key Question 1: Quality of comparisons evidence Summary … Summary of Comparative Data on Treatments of GERD (continued) Key Question 1: Quality of comparisons … Key Question 2: Quality of modifying factors evidence Summary/conclusion/comments Weak Data largely … Summary of Comparative Data on Treatments of GERD (continued) Key Question 3: Quality of adverse events

445. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/preterm-birth-terbutaline-pump_research-protocol.pdf
     October 18, 2010 - A question raised by an individual concerned whether the review will examine outcomes specific to women … with decreased cervical length and/or women with a positive fetal fibronectin test for Key Question … Key question 5 This question aims to further explore reasons for heterogeneity in outcomes by examining … This, we think, is a question that is unnecessary and not applicable for our primary studies. … Justification: This is essentially the same question as another one we ask while assessing risk of

446. Evidence Summary-Comparative-Effectiveness-Review-213-Lower-Limb-Prostheses (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-213-lower-limb-protheses-evidence-summary.pdf
     September 01, 2018 - Key Question 2. … Key Question 3. … Key Question 5. Expectations of Ambulation We found no study that addressed this key question. … Key Question 6. Patient Satisfaction With Process Two studies addressed this Key Question. … Note that this Key Question did not address satisfaction with the LLP itself.

447. Evidence-based Practice Center Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-surveillance_research-protocol.pdf
     May 19, 2011 - —EDITOR] Question 1 How have the patient population and the natural history of prostate cancer … Differences in geographical access Question 2 How are active surveillance and other observational … Behavioral indicators Question 3 What factors affect the offer of, acceptance, and adherence … Decisionmaking tools and aids Question 4 What are the comparative short- and long-term outcomes … Costs Question 5 What are the research needs regarding active surveillance (or watchful waiting

448. Template for Draft Reports (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoarthritis-knee-future_research.pdf
     February 01, 2013 - Analytic framework KQ = Key Question; OA = osteoarthritis; PT = physical therapy … Stakeholders brought up this question as a research gap. … If a stakeholder assigned a question the number one priority, that question received four points; … First topical research need: research design considerations Research Question: Which PT treatments … Stakeholders brought up this question as a research gap.

449. Future Research Needs for Noncyclic Chronic Pelvic Pain Therapies for Women (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/pelvic-pain-therapies-future_research.pdf
     January 01, 2015 - Key Question 2. … Key Question 3. … Key Question 4. … Key Question 5. … interventions (Key Question 5).

450. Acs-Pci-Adjunctive-Devices Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/acs-pci-adjunctive-devices_research-protocol.pdf
     July 01, 2010 - The Key Questions Question 1 In patients with ACS who are undergoing PCI of native vessels, what … Question 2 In patients with ACS who are undergoing PCI of native vessels, how does the rate and type … Question 3 In patients with ACS who are undergoing PCI of native vessels, which patient characteristics … Grading the Evidence for Each Key Question We will use the Grading of Recommendations Assessment, … The evidence pertaining to each key question will be classified into three broad categories: high, moderate

451. Methods Future Research Needs Number 8: Framework for Considering Study Designs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/study-design-framework_research.pdf
     March 01, 2012 - However, many reviews find only low or insufficient SOE to address a given key question. … the problem, studies that replicate the same methodological problems are unlikely to resolve the question … If a question cannot be answered because all existing studies only measured surrogate markers, additional … The advantages and disadvantages of a study design may change depending on the study question or the … The urgency with which an answer to the research question is needed may be an additional ethical

452. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism_research-protocol.pdf
     December 09, 2009 - In addition, Key Question 5 specifically addresses the question of effectiveness of individual components … abstracted from data presented in the papers • Sample sizes must be appropriate for the study question … dimensions (i.e., areas of special focus, or the columns) of each evidence table will vary by key question … Grading the Evidence for Each Key Question Quality grading. … develop explicit criteria for rating the overall strength of the collective evidence on each key question

453. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/therapies-for-autism-spectrum-disorder-2-9-2010.pdf
     January 01, 2010 - In addition, Key Question 5 specifically addresses the question of effectiveness of individual components … abstracted from data presented in the papers • Sample sizes must be appropriate for the study question … dimensions (i.e., areas of special focus, or the columns) of each evidence table will vary by key question … Grading the Evidence for Each Key Question Quality grading. … develop explicit criteria for rating the overall strength of the collective evidence on each key question

454. Disposition of Comments Technical Brief 30 Assessment Tools for Palliative Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/palliative-care-tools-disposition.pdf
     May 04, 2017 - When data do not exist specific to a question, it would have helped a comprehensive response to the … and compiled tool characteristics by domain • Guiding Question 2: we described the current state … Question 3 on the questionnaire for this group delineates on line 20, page C-1 ". . .what do doctors … They did not have much feedback regarding this question. … . 28 Peer Reviewer #3 Methods Page C-2 Questions for the Providers--asks in Question 7, line 57,

455. Disposition of Comments Technical Brief 30 Assessment Tools for Palliative Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/palliative-care-tools-disposition.pdf
     May 04, 2017 - When data do not exist specific to a question, it would have helped a comprehensive response to the … and compiled tool characteristics by domain • Guiding Question 2: we described the current state … Question 3 on the questionnaire for this group delineates on line 20, page C-1 ". . .what do doctors … They did not have much feedback regarding this question. … . 28 Peer Reviewer #3 Methods Page C-2 Questions for the Providers--asks in Question 7, line 57,

456. Research Protocol: Diabetes Medications for Adults With Type 2 Diabetes: An Update Focused on Monotherapy and Add-On Therapy to Metformin (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-update-2015_research-protocol.pdf
     January 01, 2015 - exclusion of lipid concentrations as an intermediate outcome.4 The proposed key questions are: Key Question … Key Question 3a: In adults age 18 or older with type 2 diabetes mellitus, what is the comparative safety … Key Question 3b: In adults age 18 or older with type 2 diabetes mellitus, what is the comparative safety … Key Question … Priority Medication Comparisons Included for Each Key Question Main Intervention Comparisons Source

457. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c_research-protocol.pdf
     November 30, 2011 - Question 2 What is the comparative effectiveness of antiviral treatments on intermediate outcomes … Source: www.effectivehealthcare.ahrq.gov Published Online: November 30, 2011 4 Question 3 … Question 4 Have improvements in intermediate outcomes (SVR, histologic changes) been shown to reduce … To identify articles relevant to each Key Question (KQ), the librarian will search the Cochrane Database … Grading the Evidence for Each Key Question We will use the methods outlined in Chapter 10 of the

458. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/undescended-testicle_research-protocol.pdf
     September 02, 2011 - 3 Source: www.effectivehealthcare.ahrq.gov Published Online: September 2, 2011 Key Question … 4 Source: www.effectivehealthcare.ahrq.gov Published Online: September 2, 2011 Key Question … The development of testicular malignancy The size, location, and function of the testes Key Question … Key Question 5 What is the nature and frequency of harms associated with workup or treatment for … Grading the Evidence for Each Key Question Assess the Strength of Evidence We will also use

459. Disposition of Comments for Pharmacokinetic/Pharmacodynamic Measures for Guiding Antibiotic Treatment for Hospital-Acquired Pneumonia (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/pneumonia-antibiotic-treatment_disposition-comments.pdf
     November 24, 2014 - The question arises how good and reproducible is bias scale? … Peer Reviewer #2 Results The results for key question 3 are unclear. Would Dr. … We agree that the reviewer’s question about how accurate and reproducible these measures are, which … There is no direct mention of PK/PD in the question at all (at least on page 7, lines 24-28). … It is disappointing that there is not more evidence pertaining directly to the PK/PD question.

460. Disseminating Findings From EPC Reports: Pilot Project of Three Products (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-disseminating-findings_0.pdf
     October 01, 2018 - in systematic review methods, experience in drafting key messages and general understanding of the question … In these cases we inserted the question used to assess the item, with the thought that the questions … Other sections of the EtD were not applicable due to the nature of the question addressed in the selected … Thus, for the criterion of “Benefits and harms” we inserted the relevant question (“how substantial … Section Question: Does different contrast media, within and between osmality classes, affect the